These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31475772)

  • 21. Inhibition of histone demethylases by 4-carboxy-2,2'-bipyridyl compounds.
    Chang KH; King ONF; Tumber A; Woon ECY; Heightman TD; McDonough MA; Schofield CJ; Rose NR
    ChemMedChem; 2011 May; 6(5):759-764. PubMed ID: 21412984
    [No Abstract]   [Full Text] [Related]  

  • 22. KDM4 Demethylases: Structure, Function, and Inhibitors.
    Jiang Y; Liu L; Yang ZQ
    Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.
    Bavetsias V; Lanigan RM; Ruda GF; Atrash B; McLaughlin MG; Tumber A; Mok NY; Le Bihan YV; Dempster S; Boxall KJ; Jeganathan F; Hatch SB; Savitsky P; Velupillai S; Krojer T; England KS; Sejberg J; Thai C; Donovan A; Pal A; Scozzafava G; Bennett JM; Kawamura A; Johansson C; Szykowska A; Gileadi C; Burgess-Brown NA; von Delft F; Oppermann U; Walters Z; Shipley J; Raynaud FI; Westaway SM; Prinjha RK; Fedorov O; Burke R; Schofield CJ; Westwood IM; Bountra C; Müller S; van Montfort RL; Brennan PE; Blagg J
    J Med Chem; 2016 Feb; 59(4):1388-409. PubMed ID: 26741168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.
    Gerken PA; Wolstenhulme JR; Tumber A; Hatch SB; Zhang Y; Müller S; Chandler SA; Mair B; Li F; Nijman SMB; Konietzny R; Szommer T; Yapp C; Fedorov O; Benesch JLP; Vedadi M; Kessler BM; Kawamura A; Brennan PE; Smith MD
    Angew Chem Int Ed Engl; 2017 Dec; 56(49):15555-15559. PubMed ID: 28976073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design, synthesis and biological profiling of new KDM4C inhibitors.
    Letfus V; Jelić D; Bokulić A; Petrinić Grba A; Koštrun S
    Bioorg Med Chem; 2020 Jan; 28(1):115128. PubMed ID: 31784197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzo[
    Kim YJ; Lee DH; Choi YS; Jeong JH; Kwon SH
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compounds and methods for inhibiting histone demethylases: a patent evaluation of US20160102096A1.
    Thaler F; Mercurio C
    Expert Opin Ther Pat; 2016 Dec; 26(12):1367-1370. PubMed ID: 27730846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of JMJD7 inhibitors with the aid of virtual screening and bioactivity evaluation.
    Zhang W; Li K; Wang T; Wu M; Li L
    Bioorg Med Chem Lett; 2021 Aug; 45():128139. PubMed ID: 34048880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a Novel Benzimidazole Pyrazolone Scaffold That Inhibits KDM4 Lysine Demethylases and Reduces Proliferation of Prostate Cancer Cells.
    Carter DM; Specker E; Przygodda J; Neuenschwander M; von Kries JP; Heinemann U; Nazaré M; Gohlke U
    SLAS Discov; 2017 Aug; 22(7):801-812. PubMed ID: 28346812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small molecule KDM4s inhibitors as anti-cancer agents.
    Lin H; Li Q; Li Q; Zhu J; Gu K; Jiang X; Hu Q; Feng F; Qu W; Chen Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):777-793. PubMed ID: 29651880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
    Berry WL; Janknecht R
    Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.
    Rose NR; Woon EC; Tumber A; Walport LJ; Chowdhury R; Li XS; King ON; Lejeune C; Ng SS; Krojer T; Chan MC; Rydzik AM; Hopkinson RJ; Che KH; Daniel M; Strain-Damerell C; Gileadi C; Kochan G; Leung IK; Dunford J; Yeoh KK; Ratcliffe PJ; Burgess-Brown N; von Delft F; Muller S; Marsden B; Brennan PE; McDonough MA; Oppermann U; Klose RJ; Schofield CJ; Kawamura A
    J Med Chem; 2012 Jul; 55(14):6639-43. PubMed ID: 22724510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors.
    Fang Z; Wang TQ; Li H; Zhang G; Wu XA; Yang L; Peng YL; Zou J; Li LL; Xiang R; Yang SY
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3201-3204. PubMed ID: 28539219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly selective inhibition of histone demethylases by de novo macrocyclic peptides.
    Kawamura A; Münzel M; Kojima T; Yapp C; Bhushan B; Goto Y; Tumber A; Katoh T; King ON; Passioura T; Walport LJ; Hatch SB; Madden S; Müller S; Brennan PE; Chowdhury R; Hopkinson RJ; Suga H; Schofield CJ
    Nat Commun; 2017 Apr; 8():14773. PubMed ID: 28382930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a new class of JMJD6 inhibitors and structure-activity relationship study.
    Wang T; Zhang R; Liu Y; Fang Z; Zhang H; Fan Y; Yang S; Xiang R
    Bioorg Med Chem Lett; 2021 Jul; 44():128109. PubMed ID: 33991627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substituted 2-(2-aminopyrimidin-4-yl)pyridine-4-carboxylates as potent inhibitors of JumonjiC domain-containing histone demethylases.
    Roatsch M; Robaa D; Pippel M; Nettleship JE; Reddivari Y; Bird LE; Hoffmann I; Franz H; Owens RJ; Schüle R; Flaig R; Sippl W; Jung M
    Future Med Chem; 2016 Sep; 8(13):1553-71. PubMed ID: 26971619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances with KDM4 Inhibitors and Potential Applications.
    Wu Q; Young B; Wang Y; Davidoff AM; Rankovic Z; Yang J
    J Med Chem; 2022 Jul; 65(14):9564-9579. PubMed ID: 35838529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme kinetic studies of histone demethylases KDM4C and KDM6A: towards understanding selectivity of inhibitors targeting oncogenic histone demethylases.
    Kristensen JB; Nielsen AL; Jørgensen L; Kristensen LH; Helgstrand C; Juknaite L; Kristensen JL; Kastrup JS; Clausen RP; Olsen L; Gajhede M
    FEBS Lett; 2011 Jun; 585(12):1951-6. PubMed ID: 21575637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family.
    Hillringhaus L; Yue WW; Rose NR; Ng SS; Gileadi C; Loenarz C; Bello SH; Bray JE; Schofield CJ; Oppermann U
    J Biol Chem; 2011 Dec; 286(48):41616-41625. PubMed ID: 21914792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural definitions of Jumonji family demethylase selectivity.
    Pilka ES; James T; Lisztwan JH
    Drug Discov Today; 2015 Jun; 20(6):743-9. PubMed ID: 25555749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.